A guy walks into a financial adviser’s office and says, “I’ve saved $250,000 and I’d like to retire next week and generate $100,000 a year from my portfolio for the rest of my life. Oh, and I want to buy a $50,000 boat.”
See Also: 8 Things No One Tells You About Retirement
Without missing a beat, the adviser replies, “That will only work if you live no longer than two years.”
The real punchline? It’s not a joke. This is a true story. And it highlights a fundamental truth about retirement planning: Many advisers are very good at their jobs, but we’re not magicians.
Top Retirement Concerns
When families first walk into my office to talk about planning for retirement, I usually hear these concerns:
“We’re concerned about running out of money even with our modest lifestyle.” “We’re concerned what we’re currently doing to prepare for retirement won’t work, but we’re scared that doing something else will be worse.” “We’re concerned about the volatility of the stock market, inflation, low interest rates, unexpected health care costs.” “Mostly, we’re concerned about living without a paycheck.”
Here are five time-tested steps that I’ve used hundreds of times to help people like you on their path to retire with confidence.
Top Healthcare Equipment Companies To Invest In Right Now: Bed Bath & Beyond Inc.(BBBY)
Bed Bath & Beyond Inc., incorporated on October 5, 1971, is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market). The Company operates in two segments: North American Retail and Institutional Sales.
The Company’s customers can purchase products from the Company either in-store, online, with a mobile device or through a contact center. The Company also operates Linen Holdings, a provider of a range of textile products, amenities and other goods to institutional customers in the hospitality, cruise line, healthcare and other industries. Additionally, the Company is a partner in a joint venture, which operates approximately seven retail stores in Mexico under the name Bed Bath & Beyond.
The Company sells a range of domestics merchandise and home furnishings. Domestics merchandise includes categories, such as bed linens and related items, bath items and kitchen textiles. Home furnishings include categories, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables and juvenile products.
The Company operates approximately 1,530 stores plus its various Websites, other interactive platforms and distribution facilities. The Company’s over 1,530 stores operate in approximately 50 states, the District of Columbia, Puerto Rico and Canada, including over 1,020 BBB stores, approximately 280 Cost Plus World Market stores, over 100 Baby stores, approximately 80 CTS stores and over 50 Harmon stores. The Company’s stores range in size from approximately 5,000 to 100,000 square feet. The Company has distribution facilities, which ship merchandise to stores and customers, totaling approximately 6.1 million square f eet consisting of over three owned and approximately 10 leas! ed facilities. The Company has approximately 813,000 square feet within over 20 leased and owned facilities for procurement and corporate office functions. In addition, the Company has over seven locations, totaling approximately 14,000 square feet, which are utilized primarily for institutional sales related functions.
Advisors’ Opinion:
- [By Monica Gerson]
Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported stronger-than-expected earnings for its fourth quarter and declared its first-ever quarterly dividend of $0.125 per share. Bed Bath & Beyond shares surged 4.49 percent to $51.00 in the after-hours trading session.
Top Healthcare Equipment Companies To Invest In Right Now: Nam Tai Electronics Inc.(NTE)
Nam Tai Electronics, Inc. provides electronics manufacturing and design services to the original equipment manufacturers of telecommunication and consumer electronic products. The company?s Consumer Electronic and Communication Products segment manufactures mobile phone accessories, such as headsets containing Bluetooth wireless technology, and phone cradles, as well as snap-on portable music speaker, FM radio adaptors, and GPS adaptors; entertainment devices, including USB Web cam for interactive games, USB microphone and converter box Karaoke, and buzzer devices for quiz games; educational products consisting of digital pens, calculators, and electronic dictionaries; and optical devices comprising CMOS imaging sensor modules for notebook computers, portable media players, and recording cameras for the automotive industry. Its Telecommunication Component Assembly segment offers subassemblies and components, such as color and monochrome LCD modules for PDA phones, smart p hones, mobile phones, and telephone systems; RF modules for integration into mobile phones; DAB modules for digital radio products, including home tuners, kitchen radios, in-car receivers, CD players, clock radios, boom boxes, midi-systems, and handheld portable devices; FPC subassemblies for LCD modules and electronic devices; FPC boards for mobile phones, PDAs, office automation, and laptop computers; front and back light panels for handheld video game devices; and high-frequency cordless telephones and home feature phones. The company?s LCD Products segment manufactures LCD panels for watches and medical instruments, white goods and industrial applications, automotive parts and appliances, car audio systems, hand held products, VoIP phones, and office automation applications. It sells its products to customers in Hong Kong, North America, Europe, Japan, the People?s Republic of China, and Korea. The company was founded in 1975 and is headquartered in Shenzhen, the Peopl e ?s Republic of China.
Advisors’ Opinion:
- [By Roberto Pedone]
Another stock that’s starting to move within range of triggering a big breakout trade is Nam Tai Electronics (NTE), which is an electronics manufacturing and design services provider to a select group of the world’s leading OEMs of telecommunications and consumer electronic products. This stock has been destroyed by the sellers so far in 2013, with shares off sharply by 41%.
If you look at the chart for Nam Tai Electronics, you’ll notice that this stock has been uptrending for the last month and change, with shares moving higher from its low of $6.05 to its recent high of $8.38 a share. During that uptrend, shares of NTE have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of NTE within range of triggering a big breakout trade.
Traders should now look for long-biased trades in NTE if it manages to break out above some key near-term overhead resistance levels at $8.38 to $8.79 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 647,483 shares. If that breakout triggers soon, then NTE will set up to re-fill some of its previous gap down zone from April that started near $11.50 a share. If this stock gets into that gap with volume, then the upside is tremendous and we could easily see NTE hit $11 to $12 a share.
Traders can look to buy NTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $7.42 a share, or below more key support at $7.22 a share. One can also buy NTE off strength once it takes out that breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Hot Insurance Companies For 2017: Whiting Petroleum Corporation(WLL)
Whiting Petroleum Corporation engages in the acquisition, development, exploitation, exploration, and production of oil and gas primarily in the Permian Basin, Rocky Mountains, Mid-Continent, Gulf Coast, and Michigan regions of the United States. As of December 31, 2010, its estimated proved reserves were 304.9 million barrels equivalent of oil; and had interests in 9,698 gross productive wells covering approximately 1,115,000 gross developed acres. The company sells its oil and gas to end users, marketers, and other purchasers. Whiting Petroleum Corporation was founded in 1983 and is Denver, Colorado.
Advisors’ Opinion:
- [By Andrew Efimoff]
WTI crude oil plunged 3.11 percent on Friday to $48.99 a barrel. Below are the biggest energy losers for the day:
California Resources Corporation (NYSE: CRC): -19.22% Dynamic Materials (NASDAQ: BOOM): -12.39% Clayton Williams Energy (NYSE: CWEI): -11.45% Dynergy (NYSE: DYN): -11.91% EP Energy Corporation (NYSE: EPE): -11.20% Mexco Energy (NYSE: MXC) -10.90% Whiting Petroleum (NYSE: WLL) -10.79% Southwestern Energy Company (NYSE: SWN) -10.79% SM Energy Company (NYSE: SM) -10.38% Real Goods Solar (NASDAQ: RGSE) -10.34%
Posted-In: Commodities After-Hours Center Markets Movers
- [By Ben Levisohn]
Shares of energy stocks, including ExxonMobil (XOM), Chevron (CVX), Whiting Petroleum (WLL), and Devon Energy (DVN), are surging on reports that OPEC has agreed to to limit the amount of oil its members produce. Bloomberg’s Nayla Razzouk,Grant Smith, and Angelina Rascouetreport:
Top Healthcare Equipment Companies To Invest In Right Now: AbbVie Inc.(ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics, Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illi! nois.
- [By Ben Levisohn]
The main conclusions we draw from the abstracts (lacking information about late breakers) is that Gileads dominance of HCV seems secure for the immediate future, with sof/vel (sofosbuvir/velpatasvir) showing impressive efficacy in difficult-to-treat patient subsets. Competitors have early data for their new HCV development efforts (Merck (MRK) [MP], Johnson & Johnson (JNJ) [OP], AbbVie (ABBV)) but will not present new clinical data at this meeting.
- [By Ben Levisohn]
After surveying doctors on the preferred hepatitis-C treatments, Baird’s Brian Skorney and Neena Bitritto-Garg contend that Gilead Sciences (GILD) is likely to maintain its dominance over AbbVie (ABBV), Merck (MRK) and Johnson & Johnson (JNJ) but in what appears to be a shrinking market. They explain:
- [By Ben Levisohn]
The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).
- [By Ben Levisohn]
Raymond James analyst Christopher Raymond and team sayAbbVie (ABBV) is “not your father’s biotech company” as they initiate coverage with an Outperform rating:
Kevin Hagen for The Wall Street Journal
Initiating coverage of ABBV shares with an Outperform rating and an $82 price target as we think uncertainty over Humira’s intellectual property (IP) creates an opportunity to own this name at a significant discount to its peers before the full extent of the drug’s revenue tail becomes reflected in the stock. Coupling that with a rapidly diversifying portfolio, numerous upcoming value-enhancing catalysts, and a decent dividend yield, we think shares can continue to work higher over the next several quarters.
Not your father’s biotech company. Having spun out of Abbott Laboratories (ABT) in 2013, and based in North Chicago, IL, AbbVie comes with a decidedly different pedigree than most biotechs. Indeed, most investors we speak with tend to lump the company in with large pharma – simply by virtue of this legacy. However, with a growth profile, product offering, and pipeline that is every bit that of a biotech company, we think this name should increasingly be viewed through such a lens…
We think the stock can continue to work from here. While Humira still accounts for ~60% of revenue, AbbVie has made great strides toward diversification (with some seen as smart deals, others – the jury is still out), all of which poise the company for significant catalyst flow, in our view. Coupling that with current mid-teens EPS growth, a dividend yield of ~3.5%, and current P/E of ~13x 2016E EPS, we like the set up here.
Shares of AbbVie are little changed at $64.06 at 3:01 p.m. today, while Abbott Laboratories has declined 0.5% to $42.07.
Top Healthcare Equipment Companies To Invest In Right Now: Protective Life Corporation(PL)
Protective Life Corporation and its subsidiaries engage in the production, distribution, and administration of insurance and investment products in the United States. Its Life Marketing segment markets universal life, variable universal life, level premium term insurance, and bank-owned life insurance products primarily through a network of independent insurance agents and brokers, stockbrokers, and independent marketing organizations. The company?s Acquisitions segment focuses on acquiring, converting, and servicing life insurance policies and annuity products sold to individuals, which are acquired from other companies. Its Annuities segment markets variable annuity products that offer the policyholder the opportunity to invest in various investment accounts; and fixed annuity products, such as modified guaranteed annuities, single premium deferred annuities, single premium immediate annuities, and equity indexed annuities primarily through broker-dealers, financial ins titutions, and independent agents and brokers. The company?s Stable Value Products segment offers guaranteed funding agreements to special purpose entities; fixed and floating rate funding agreements directly to the trustees of municipal bond proceeds, institutional investors, bank trust departments, and money market funds; and guaranteed investment contracts to qualified retirement savings plans. Its Asset Protection segment primarily markets extended service contracts, and credit life and disability insurance to protect consumers? investments in automobiles, watercraft, and recreational vehicles; and markets a guaranteed asset protection product primarily through a national network of approximately 3,750 automobile, marine, and recreational vehicle dealers. The company was founded in 1907 and is headquartered in Birmingham, Alabama.
Advisors’ Opinion:
- [By David Sterman]
My favorite insurers: AIG (NYSE: AIG) (which I discussed a few months ago), Protective Life (NYSE: PL) and Reinsurance Group of America (NYSE: RGA).